Artykuły w czasopismach na temat „Kallikrein-Related peptidase 5”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Kallikrein-Related peptidase 5”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
Ismail, Maha Imam Ahmed, *. Manal Basyouni Ahmed * Manal Basyouni Ahmed i Muneera Al-Sheeha. "Evaluation of kallikrein-related peptidase 5 [KLK5] and Survivin as Prognostic Markers in Breast Cancer". International Journal of Scientific Research 3, nr 5 (1.06.2012): 398–401. http://dx.doi.org/10.15373/22778179/may2014/124.
Pełny tekst źródłaZingkou, Eleni, Georgios Pampalakis i Georgia Sotiropoulou. "Exacerbated dandruff in the absence of kallikrein‐related peptidase 5 protease". Journal of Dermatology 47, nr 3 (7.01.2020): 311–13. http://dx.doi.org/10.1111/1346-8138.15174.
Pełny tekst źródłaSidiropoulos, Konstantinos G., Nicole M. A. White, Anna Bui, Qiang Ding, Peter Boulos, Georgios Pampalakis, Heba Khella, Joseph N. Samuel, Georgia Sotiropoulou i George M. Yousef. "Kallikrein-related peptidase 5 induces miRNA-mediated anti-oncogenic pathways in breast cancer". Oncoscience 1, nr 11 (24.10.2014): 709–24. http://dx.doi.org/10.18632/oncoscience.91.
Pełny tekst źródłaMalachias, Apostolos, Georgia Papachristopoulou, Dimitrios Kypraios, Stefanos P. Bassioukas, Maria Nikaki, Dimitrios Xinopoulos i Maroulio Talieri. "Sa1973 Analysis and Clinical Evaluation of Kallikrein-Related Peptidase 5 (KLK5) in Colon Cancer". Gastroenterology 148, nr 4 (kwiecień 2015): S—372. http://dx.doi.org/10.1016/s0016-5085(15)31246-4.
Pełny tekst źródłaOrtloff, A., F. A. Bustamante, L. Molina, J. Ojeda, C. D. Figueroa i P. Ehrenfeld. "Kallikrein-related Peptidase 5 (KLK5) Expression and Distribution in Canine Cutaneous Squamous Cell Carcinoma". Journal of Comparative Pathology 174 (styczeń 2020): 113–19. http://dx.doi.org/10.1016/j.jcpa.2019.11.009.
Pełny tekst źródłaSakabe, Jun-ichi, Mami Yamamoto, Satoshi Hirakawa, Akira Motoyama, Isao Ohta, Kazuki Tatsuno, Taisuke Ito, Kenji Kabashima, Toshihiko Hibino i Yoshiki Tokura. "Kallikrein-related Peptidase 5 Functions in Proteolytic Processing of Profilaggrin in Cultured Human Keratinocytes". Journal of Biological Chemistry 288, nr 24 (29.04.2013): 17179–89. http://dx.doi.org/10.1074/jbc.m113.476820.
Pełny tekst źródłaLin, Yongbo, Li Ma, Hanliang Dan, Gang Chen, Jian Dai, Liang Xu i Yuqi Liu. "MiR-107-3p Knockdown Alleviates Endothelial Injury in Sepsis via Kallikrein-Related Peptidase 5". Journal of Surgical Research 292 (grudzień 2023): 264–74. http://dx.doi.org/10.1016/j.jss.2023.07.013.
Pełny tekst źródłaYoon, Hyesook, i Isobel A. Scarisbrick. "Kallikrein-related peptidase 6 exacerbates disease in an autoimmune model of multiple sclerosis". Biological Chemistry 397, nr 12 (1.12.2016): 1277–86. http://dx.doi.org/10.1515/hsz-2016-0239.
Pełny tekst źródłaWu, Yanhua, Yingjian Chen, Qing Li, Yanwen Gong, Xiaohong Liu, Liquan Bi i Chengjin Hu. "Upregulation of kallikrein-related peptidase 5 is associated with the malignant behavior of colorectal cancer". Molecular Medicine Reports 14, nr 3 (13.07.2016): 2164–70. http://dx.doi.org/10.3892/mmr.2016.5516.
Pełny tekst źródłaPetraki, Constantina, Youssef M. Youssef, William Dubinski, Zsuzsanna Lichner, Andreas Scorilas, Maria D. Pasic, Vassilios Komborozos i in. "Evaluation and prognostic significance of human tissue kallikrein-related peptidase 10 (KLK10) in colorectal cancer". Tumor Biology 33, nr 4 (22.03.2012): 1209–14. http://dx.doi.org/10.1007/s13277-012-0368-5.
Pełny tekst źródłaMagnen, Mélia, Brigitta Margit Elsässer, Olga Zbodakova, Petr Kasparek, Fabien Gueugnon, Agnès Petit-Courty, Radislav Sedlacek, Peter Goettig i Yves Courty. "Kallikrein-related peptidase 5 and seasonal influenza viruses, limitations of the experimental models for activating proteases". Biological Chemistry 399, nr 9 (25.09.2018): 1053–64. http://dx.doi.org/10.1515/hsz-2017-0340.
Pełny tekst źródłaMontenegro, Sara Estefania, Jang-Hee Oh, Joong Heon Suh, Je-Ho Mun i Jin Ho Chung. "Higher Expression of Lympho-epithelial Kazal-type-Related Inhibitor-1 Fragments and Decreased Desquamation in the Lesional Skin of Nummular Eczema". Acta Dermato-Venereologica 104 (29.03.2024): adv188636. http://dx.doi.org/10.2340/actadv.v104.18636.
Pełny tekst źródłaNohara, Kyoko, Kazuhiko Yamada, Leo Yamada, Teruki Hagiwara, Toru Igari, Chizu Yokoi, Daisuke Soma, Satoshi Yamashita, Taeko Dohi i Yuki I. Kawamura. "Expression of kallikrein-related peptidase 13 is associated with poor prognosis in esophageal squamous cell carcinoma". General Thoracic and Cardiovascular Surgery 66, nr 6 (26.03.2018): 351–57. http://dx.doi.org/10.1007/s11748-018-0910-5.
Pełny tekst źródłaLee, Chia-Yao, David Marzan, Grace Lin, Steve Goodison i Steve Silletti. "α2 Integrin-Dependent Suppression of Pancreatic Adenocarcinoma Cell Invasion Involves Ectodomain Regulation of Kallikrein-Related Peptidase-5". Journal of Oncology 2011 (2011): 1–15. http://dx.doi.org/10.1155/2011/365651.
Pełny tekst źródłade Veer, Simon J., Joakim E. Swedberg, Maria Brattsand, Judith A. Clements i Jonathan M. Harris. "Exploring the active site binding specificity of kallikrein-related peptidase 5 (KLK5) guides the design of new peptide substrates and inhibitors". Biological Chemistry 397, nr 12 (1.12.2016): 1237–49. http://dx.doi.org/10.1515/hsz-2016-0112.
Pełny tekst źródłaPapachristopoulou, Georgia, Apostolos Malachias, Marina Devetzi, Evdoxia Kamouza, Andreas Scorilas, Dimitris Xynopoulos i Maroulio Talieri. "Uncovering the clinical impact of kallikrein-related peptidase 5 (KLK5) mRNA expression in the colorectal adenoma-carcinoma sequence". Clinical Chemistry and Laboratory Medicine (CCLM) 57, nr 8 (26.07.2019): 1251–60. http://dx.doi.org/10.1515/cclm-2018-1010.
Pełny tekst źródłaBandiera, Elisabetta, Laura Zanotti, Eliana Bignotti, Chiara Romani, Renata Tassi, Paola Todeschini, Germana Tognon i in. "Human Kallikrein 5: An Interesting Novel Biomarker in Ovarian Cancer Patients That Elicits Humoral Response". International Journal of Gynecologic Cancer 19, nr 6 (lipiec 2009): 1015–21. http://dx.doi.org/10.1111/igc.0b013e3181ab597f.
Pełny tekst źródłaPampalakis, Georgios, Eleni Zingkou i Georgia Sotiropoulou. "KLK5, a novel potential suppressor of vaginal carcinogenesis". Biological Chemistry 399, nr 9 (25.09.2018): 1107–11. http://dx.doi.org/10.1515/hsz-2017-0302.
Pełny tekst źródłaFurio, Laetitia, Simon de Veer, Madeleine Jaillet, Anais Briot, Aurelie Robin, Celine Deraison i Alain Hovnanian. "Transgenic kallikrein 5 mice reproduce major cutaneous and systemic hallmarks of Netherton syndrome". Journal of Experimental Medicine 211, nr 3 (17.02.2014): 499–513. http://dx.doi.org/10.1084/jem.20131797.
Pełny tekst źródłaWu, Yanhua, Xiaofei Liu, Yingjian Chen i Chengjin Hu. "Development and evaluation of an ELISA method for the measurement of kallikrein-related peptidase 5 (KLK5) in human serum". Open Journal of Clinical Diagnostics 03, nr 04 (2013): 159–66. http://dx.doi.org/10.4236/ojcd.2013.34029.
Pełny tekst źródłaMeyer-Hoffert, Ulf, Zhihong Wu i Jens-Michael Schröder. "Identification of Lympho-Epithelial Kazal-Type Inhibitor 2 in Human Skin as a Kallikrein-Related Peptidase 5-Specific Protease Inhibitor". PLoS ONE 4, nr 2 (3.02.2009): e4372. http://dx.doi.org/10.1371/journal.pone.0004372.
Pełny tekst źródłaPlanque, Chris, Yun-Hee Choi, Serge Guyetant, Nathalie Heuzé-Vourc'h, Laurent Briollais i Yves Courty. "Alternative Splicing Variant of Kallikrein-Related Peptidase 8 as an Independent Predictor of Unfavorable Prognosis in Lung Cancer". Clinical Chemistry 56, nr 6 (1.06.2010): 987–97. http://dx.doi.org/10.1373/clinchem.2009.138917.
Pełny tekst źródłaReid, Janet C., Nigel C. Bennett, Carson R. Stephens, Melanie L. Carroll, Viktor Magdolen, Judith A. Clements i John D. Hooper. "In vitro evidence that KLK14 regulates the components of the HGF/Met axis, pro-HGF and HGF-activator inhibitor 1A and 1B". Biological Chemistry 397, nr 12 (1.12.2016): 1299–305. http://dx.doi.org/10.1515/hsz-2016-0163.
Pełny tekst źródłaAvgeris, Margaritis, Georgia Papachristopoulou, Athanasios Polychronis i Andreas Scorilas. "Down-regulation of kallikrein-related peptidase 5 (KLK5) expression in breast cancer patients: a biomarker for the differential diagnosis of breast lesions". Clinical Proteomics 8, nr 1 (2011): 5. http://dx.doi.org/10.1186/1559-0275-8-5.
Pełny tekst źródłaWeidinger, Stephan, Hansjörg Baurecht, Stefan Wagenpfeil, John Henderson, Natalija Novak, Aileen Sandilands, Huijia Chen i in. "Analysis of the individual and aggregate genetic contributions of previously identified serine peptidase inhibitor Kazal type 5 (SPINK5), kallikrein-related peptidase 7 (KLK7), and filaggrin (FLG) polymorphisms to eczema risk". Journal of Allergy and Clinical Immunology 122, nr 3 (wrzesień 2008): 560–68. http://dx.doi.org/10.1016/j.jaci.2008.05.050.
Pełny tekst źródłaBrännström, Kristoffer, Anders Öhman, Ulrich von Pawel Rammingen, Anders Olofsson i Maria Brattsand. "Characterization of SPINK9, a KLK5-specific inhibitor expressed in palmo-plantar epidermis". Biological Chemistry 393, nr 5 (1.05.2012): 369–77. http://dx.doi.org/10.1515/hsz-2011-0238.
Pełny tekst źródłaFukushima, Tsuyoshi, Shuichiro Uchiyama, Hiroyuki Tanaka i Hiroaki Kataoka. "Hepatocyte Growth Factor Activator: A Proteinase Linking Tissue Injury with Repair". International Journal of Molecular Sciences 19, nr 11 (1.11.2018): 3435. http://dx.doi.org/10.3390/ijms19113435.
Pełny tekst źródłaNomura, Hayato, Mutsumi Suganuma, Takuya Takeichi, Michihiro Kono, Yuki Isokane, Ko Sunagawa, Mina Kobashi i in. "Multifaceted Analyses of Epidermal Serine Protease Activity in Patients with Atopic Dermatitis". International Journal of Molecular Sciences 21, nr 3 (30.01.2020): 913. http://dx.doi.org/10.3390/ijms21030913.
Pełny tekst źródłaIshida, Koichi, Liyue Qin, Ting Wang, Ying Lei, Weiwei Hu, Geng Zhu, Qianqian Zhuang i in. "Local mechanisms for acupoint sensitization in gall bladder meridian of foot shaoyang-a gene chip study". Acupuncture & Electro-Therapeutics Research 44, nr 2 (1.06.2019): 77–87. http://dx.doi.org/10.3727/036012919x15650315071898.
Pełny tekst źródłaSchaap, Mirjam J., Finola M. Bruins, Xuehui He, Kadri Orro, Malou Peppelman, Piet E. J. van Erp, Elke M. G. J. de Jong, Hans J. P. M. Koenen, Ellen H. van den Bogaard i Marieke M. B. Seyger. "Skin Surface Protein Detection by Transdermal Analysis Patches in Pediatric Psoriasis". Skin Pharmacology and Physiology 34, nr 5 (2021): 271–80. http://dx.doi.org/10.1159/000516110.
Pełny tekst źródłaBeaufort, Nathalie, Karolina Plaza, Daniel Utzschneider, Amelie Schwarz, Julia M. Burkhart, Sabine Creutzburg, Mekdes Debela, Manfred Schmitt, Christian Ries i Viktor Magdolen. "Interdependence of kallikrein-related peptidases in proteolytic networks". Biological Chemistry 391, nr 5 (1.05.2010): 581–87. http://dx.doi.org/10.1515/bc.2010.055.
Pełny tekst źródłaJung, Monika, Annika Schaefer, Isabel Steiner, Carsten Kempkensteffen, Carsten Stephan, Andreas Erbersdobler i Klaus Jung. "Robust MicroRNA Stability in Degraded RNA Preparations from Human Tissue and Cell Samples". Clinical Chemistry 56, nr 6 (1.06.2010): 998–1006. http://dx.doi.org/10.1373/clinchem.2009.141580.
Pełny tekst źródłaPathak, Monika, Szu Shen Wong, Ingrid Dreveny i Jonas Emsley. "Structure of plasma and tissue kallikreins". Thrombosis and Haemostasis 110, nr 09 (2013): 423–33. http://dx.doi.org/10.1160/th12-11-0840.
Pełny tekst źródłaChee, Jessica, Jasmine Singh, Anupam Naran, Neil L. Misso, Philip J. Thompson i Kanti D. Bhoola. "Novel expression of kallikreins, kallikrein-related peptidases and kinin receptors in human pleural mesothelioma". Biological Chemistry 388, nr 11 (1.11.2007): 1235–42. http://dx.doi.org/10.1515/bc.2007.139.
Pełny tekst źródłaSarwar, Md Shahid, Christina N. Ramirez, Hsiao-Chen Dina Kuo, Pochung Chou, Renyi Wu, Davit Sargsyan, Ahmad Shannar i in. "Abstract 5266: Metabolic rewiring and epigenetic reprogramming by the environmental carcinogen benzo[a]pyrene in a two-stage skin carcinogenesis mouse model and cancer interception by triterpenoid ursolic acid". Cancer Research 83, nr 7_Supplement (4.04.2023): 5266. http://dx.doi.org/10.1158/1538-7445.am2023-5266.
Pełny tekst źródłaHamilton, Brian S., i Gary R. Whittaker. "Cleavage Activation of Human-adapted Influenza Virus Subtypes by Kallikrein-related Peptidases 5 and 12". Journal of Biological Chemistry 288, nr 24 (23.04.2013): 17399–407. http://dx.doi.org/10.1074/jbc.m112.440362.
Pełny tekst źródłaWang, Ping, Viktor Magdolen, Christof Seidl, Julia Dorn, Enken Drecoll, Matthias Kotzsch, Feng Yang i in. "Kallikrein-related peptidases 4, 5, 6 and 7 regulate tumour-associated factors in serous ovarian cancer". British Journal of Cancer 119, nr 7 (październik 2018): 1–9. http://dx.doi.org/10.1038/s41416-018-0260-1.
Pełny tekst źródłaKeuylian, Zela, i Alain Hovnanian. "Mechanistic insight from murine models of Netherton syndrome". Biological Chemistry 397, nr 12 (1.12.2016): 1223–28. http://dx.doi.org/10.1515/hsz-2016-0203.
Pełny tekst źródłaOlkhov, E., T. H. Van Der Kwast, K. Kron, V. Pethe, H. Ozcelik, L. Briollais, N. E. Fleshner, E. P. Diamandis, A. R. Zlotta i B. Bapat. "543 Methylation of Kallikrein-related peptidases as novel diagnostic and prognostic biomarkers for prostate cancer". European Urology Supplements 11, nr 1 (luty 2012): e543-e543a. http://dx.doi.org/10.1016/s1569-9056(12)60540-5.
Pełny tekst źródłaEhrenfeld, Pamela, Carlos D. Figueroa, Luis Molina, Tania Koning, Myriam Velasco, Felipe A. Bustamante-Barrientos i Alexander Ortloff. "Expression and Distribution of Kallikrein-related Peptidases 5, 7, 8 and 10 in Normal Apocrine Gland of Canine Skin". International Journal of Morphology 41, nr 1 (luty 2023): 210–15. http://dx.doi.org/10.4067/s0717-95022023000100210.
Pełny tekst źródłaShahinian, Hasmik, Daniela Loessner, Martin L. Biniossek, Jayachandran N. Kizhakkedathu, Judith A. Clements, Viktor Magdolen i Oliver Schilling. "Secretome and degradome profiling shows that Kallikrein-related peptidases 4, 5, 6, and 7 induce TGFβ-1 signaling in ovarian cancer cells". Molecular Oncology 8, nr 1 (1.10.2013): 68–82. http://dx.doi.org/10.1016/j.molonc.2013.09.003.
Pełny tekst źródłaJendrny, Cathleen, i Annette G. Beck-Sickinger. "Inhibition of Kallikrein-Related Peptidases 7 and 5 by Grafting Serpin Reactive-Center Loop Sequences onto Sunflower Trypsin Inhibitor-1 (SFTI-1)". ChemBioChem 17, nr 8 (22.12.2015): 719–26. http://dx.doi.org/10.1002/cbic.201500539.
Pełny tekst źródłaBarabe, J., D. Huberdeau i A. Bernoussi. "Influence of sodium balance on urinary excretion of immunoreactive kinins in rats". American Journal of Physiology-Renal Physiology 254, nr 4 (1.04.1988): F484—F491. http://dx.doi.org/10.1152/ajprenal.1988.254.4.f484.
Pełny tekst źródłaThomadaki, Hellinida, Konstantinos Mavridis, Maroulio Talieri i Andreas Scorilas. "Treatment of PC3 prostate cancer cells with mitoxantrone, etoposide, doxorubicin and carboplatin induces distinct alterations in the expression of kallikreins 5 and 11". Thrombosis and Haemostasis 101, nr 02 (2009): 373–80. http://dx.doi.org/10.1160/th08-01-0025.
Pełny tekst źródłaJendrny, Cathleen, i Annette G. Beck-Sickinger. "Inside Back Cover: Inhibition of Kallikrein-Related Peptidases 7 and 5 by Grafting Serpin Reactive-Center Loop Sequences onto Sunflower Trypsin Inhibitor-1 (SFTI-1) (ChemBioChem 8/2016)". ChemBioChem 17, nr 8 (5.04.2016): 784. http://dx.doi.org/10.1002/cbic.201600146.
Pełny tekst źródłaChavakis, Triantafyllos, Sandip M. Kanse, Florea Lupu, Hans-Peter Hammes, Werner Müller-Esterl, Robin A. Pixley, Robert W. Colman i Klaus T. Preissner. "Different mechanisms define the antiadhesive function of high molecular weight kininogen in integrin- and urokinase receptor–dependent interactions". Blood 96, nr 2 (15.07.2000): 514–22. http://dx.doi.org/10.1182/blood.v96.2.514.
Pełny tekst źródłaChavakis, Triantafyllos, Sandip M. Kanse, Florea Lupu, Hans-Peter Hammes, Werner Müller-Esterl, Robin A. Pixley, Robert W. Colman i Klaus T. Preissner. "Different mechanisms define the antiadhesive function of high molecular weight kininogen in integrin- and urokinase receptor–dependent interactions". Blood 96, nr 2 (15.07.2000): 514–22. http://dx.doi.org/10.1182/blood.v96.2.514.014k45_514_522.
Pełny tekst źródłaLuo, Yanmin, Premlata Kumar i Carole R. Mendelson. "Estrogen-Related Receptor γ (ERRγ) Regulates Oxygen-Dependent Expression of Voltage-gated Potassium (K+) Channels and Tissue Kallikrein during Human Trophoblast Differentiation". Molecular Endocrinology 27, nr 6 (1.06.2013): 940–52. http://dx.doi.org/10.1210/me.2013-1038.
Pełny tekst źródłaBandiera, Elisabetta, Laura Zanotti, Eliana Bignotti, Chiara Romani, Renata Tassi, Paola Todeschini, Germana Tognon i in. "Human Kallikrein 5: An Interesting Novel Biomarker in Ovarian Cancer Patients that Elicits a Humoral Response". International Journal of Biological Markers 24, nr 3 (lipiec 2009): 211. http://dx.doi.org/10.1177/172460080902400337.
Pełny tekst źródłaDong, Y., L. T. Bui, D. M. Odorico, O. L. Tan, S. A. Myers, H. Samaratunga, R. A. Gardiner i J. A. Clements. "Compartmentalized expression of kallikrein 4 (KLK4/hK4) isoforms in prostate cancer: nuclear, cytoplasmic and secreted forms". Endocrine-Related Cancer 12, nr 4 (grudzień 2005): 875–89. http://dx.doi.org/10.1677/erc.1.01062.
Pełny tekst źródła